Prevalence and molecular characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis isolates from Southern China

Abstract Background Pyrazinamide (PZA) plays a unique role in the treatment for multidrug-resistant tuberculosis (MDR-TB) in both first- and second-line regimens. The aim of this study was to investigate the prevalence and molecular characterization of PZA resistance among MDR-TB isolates collected...

Full description

Bibliographic Details
Main Authors: Yu Pang, Damian Zhu, Huiwen Zheng, Jing Shen, Yan Hu, Jie Liu, Yanlin Zhao
Format: Article
Language:English
Published: BMC 2017-11-01
Series:BMC Infectious Diseases
Online Access:http://link.springer.com/article/10.1186/s12879-017-2761-6
id doaj-1d34afff2ae741ffbf7a72a979537a04
record_format Article
spelling doaj-1d34afff2ae741ffbf7a72a979537a042020-11-25T02:36:40ZengBMCBMC Infectious Diseases1471-23342017-11-011711810.1186/s12879-017-2761-6Prevalence and molecular characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis isolates from Southern ChinaYu Pang0Damian Zhu1Huiwen Zheng2Jing Shen3Yan Hu4Jie Liu5Yanlin Zhao6National Clinical Laboratory on Tuberculosis, Beijing Key Laboratory on Drug-Resistant Tuberculosis Research, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumor InstituteClinical Laboratory, Chongqing Tuberculosis Control InstituteNational Center for Tuberculosis Control and Prevention, Chinese Center for Disease Control and PreventionClinical Laboratory, Chongqing Tuberculosis Control InstituteClinical Laboratory, Chongqing Tuberculosis Control InstituteClinical Laboratory, Chongqing Tuberculosis Control InstituteNational Center for Tuberculosis Control and Prevention, Chinese Center for Disease Control and PreventionAbstract Background Pyrazinamide (PZA) plays a unique role in the treatment for multidrug-resistant tuberculosis (MDR-TB) in both first- and second-line regimens. The aim of this study was to investigate the prevalence and molecular characterization of PZA resistance among MDR-TB isolates collected in Chongqing municipality. Methods A total of 133 MDR-TB isolates were collected from the smear-positive tuberculosis patients who were registered at local TB dispensaries of Chongqing. PZA susceptibility testing was determined with a Bactec MGIT 960 system. In addition, the genes conferring for PZA resistance were screened by DNA sequencing. Results Of these 133 MDR-TB isolates, 83 (62.4%) were determined as PZA-resistant by MGIT 960. In addition, streptomycin- (83.1% vs. 56.0%, P < 0.01), ofloxacin- (51.8% vs. 18.0%, P < 0.01), kanamycin- (22.9% vs. 2.0%, P < 0.01), amikacin- (18.1% vs. 2.0%, P = 0.01), capromycin-resistance (12.0% vs. 2.0%, P = 0.05), were more frequently observed among PZA-resistant isolates compared with PZA-susceptible isolates. Sequence analysis revealed that 73 out of 83 (88.0%) MDR strains harbored a mutation located in the pncA gene, including 55 (75.3%, 55/73) of single nucleotide substitutions and 18 (24.7%, 18/73) of frameshift mutation, while no genetic mutation associated with PZA resistance was found in the rpsA gene. The pncA expression of strains harboring substitution from A to G at position −11 in the promoter region of pncA was significantly lower than that of H37Rv (P < 0.01). Conclusions In conclusion, our data have demonstrated that the analysis of the pncA gene rather than rpsA gene provides rapid and accurate information regarding PZA susceptibility for MDR-TB isolates in Chongqing. In addition, loss of pncA expression caused by promoter mutation confers PZA resistance in MDR-TB isolates.http://link.springer.com/article/10.1186/s12879-017-2761-6
collection DOAJ
language English
format Article
sources DOAJ
author Yu Pang
Damian Zhu
Huiwen Zheng
Jing Shen
Yan Hu
Jie Liu
Yanlin Zhao
spellingShingle Yu Pang
Damian Zhu
Huiwen Zheng
Jing Shen
Yan Hu
Jie Liu
Yanlin Zhao
Prevalence and molecular characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis isolates from Southern China
BMC Infectious Diseases
author_facet Yu Pang
Damian Zhu
Huiwen Zheng
Jing Shen
Yan Hu
Jie Liu
Yanlin Zhao
author_sort Yu Pang
title Prevalence and molecular characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis isolates from Southern China
title_short Prevalence and molecular characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis isolates from Southern China
title_full Prevalence and molecular characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis isolates from Southern China
title_fullStr Prevalence and molecular characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis isolates from Southern China
title_full_unstemmed Prevalence and molecular characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis isolates from Southern China
title_sort prevalence and molecular characterization of pyrazinamide resistance among multidrug-resistant mycobacterium tuberculosis isolates from southern china
publisher BMC
series BMC Infectious Diseases
issn 1471-2334
publishDate 2017-11-01
description Abstract Background Pyrazinamide (PZA) plays a unique role in the treatment for multidrug-resistant tuberculosis (MDR-TB) in both first- and second-line regimens. The aim of this study was to investigate the prevalence and molecular characterization of PZA resistance among MDR-TB isolates collected in Chongqing municipality. Methods A total of 133 MDR-TB isolates were collected from the smear-positive tuberculosis patients who were registered at local TB dispensaries of Chongqing. PZA susceptibility testing was determined with a Bactec MGIT 960 system. In addition, the genes conferring for PZA resistance were screened by DNA sequencing. Results Of these 133 MDR-TB isolates, 83 (62.4%) were determined as PZA-resistant by MGIT 960. In addition, streptomycin- (83.1% vs. 56.0%, P < 0.01), ofloxacin- (51.8% vs. 18.0%, P < 0.01), kanamycin- (22.9% vs. 2.0%, P < 0.01), amikacin- (18.1% vs. 2.0%, P = 0.01), capromycin-resistance (12.0% vs. 2.0%, P = 0.05), were more frequently observed among PZA-resistant isolates compared with PZA-susceptible isolates. Sequence analysis revealed that 73 out of 83 (88.0%) MDR strains harbored a mutation located in the pncA gene, including 55 (75.3%, 55/73) of single nucleotide substitutions and 18 (24.7%, 18/73) of frameshift mutation, while no genetic mutation associated with PZA resistance was found in the rpsA gene. The pncA expression of strains harboring substitution from A to G at position −11 in the promoter region of pncA was significantly lower than that of H37Rv (P < 0.01). Conclusions In conclusion, our data have demonstrated that the analysis of the pncA gene rather than rpsA gene provides rapid and accurate information regarding PZA susceptibility for MDR-TB isolates in Chongqing. In addition, loss of pncA expression caused by promoter mutation confers PZA resistance in MDR-TB isolates.
url http://link.springer.com/article/10.1186/s12879-017-2761-6
work_keys_str_mv AT yupang prevalenceandmolecularcharacterizationofpyrazinamideresistanceamongmultidrugresistantmycobacteriumtuberculosisisolatesfromsouthernchina
AT damianzhu prevalenceandmolecularcharacterizationofpyrazinamideresistanceamongmultidrugresistantmycobacteriumtuberculosisisolatesfromsouthernchina
AT huiwenzheng prevalenceandmolecularcharacterizationofpyrazinamideresistanceamongmultidrugresistantmycobacteriumtuberculosisisolatesfromsouthernchina
AT jingshen prevalenceandmolecularcharacterizationofpyrazinamideresistanceamongmultidrugresistantmycobacteriumtuberculosisisolatesfromsouthernchina
AT yanhu prevalenceandmolecularcharacterizationofpyrazinamideresistanceamongmultidrugresistantmycobacteriumtuberculosisisolatesfromsouthernchina
AT jieliu prevalenceandmolecularcharacterizationofpyrazinamideresistanceamongmultidrugresistantmycobacteriumtuberculosisisolatesfromsouthernchina
AT yanlinzhao prevalenceandmolecularcharacterizationofpyrazinamideresistanceamongmultidrugresistantmycobacteriumtuberculosisisolatesfromsouthernchina
_version_ 1724798762039115776